We treated mice with a panel of anti-CD44 antibodies in comparison to anti-platelet antibody, and found that while the CD44 antibodies induced thrombocytopenia and were effective in ameliorating arthritis at the concentrations used, the therapeutic effect did not appear to be closely related to the severity or length of the thrombocytopenia. Here, CD44 is linked to arthritic joint disease.